
When should you boost your supplemental life insurance? Experts weigh in
Supplemental life insurance can provide critical financial protection that you may otherwise miss out on.
Getty Images
The majority of American workers — 53% in 2024 — have life insurance through their workplace, according to LIMRA. However, as the cost of living rises, most workplace life insurance policies fail to keep pace. The median basic workplace coverage is just $20,000 or one times a worker's salary, which likely isn't enough to provide for your family if you pass away, the survey notes.
"A basic group life policy from your employer, usually one to two times your salary, just isn't enough in today's world," says Michael Foguth, founder of Foguth Financial Group. "If you have a mortgage, kids, or even significant debt, supplemental life insurance can be a game-changer."
And even if you have significantly more coverage, it likely isn't keeping up with the cost of living. Unfortunately, far too many people are just relying on their employer's plan.
That's where supplemental coverage comes in. Supplemental life insurance, referring to a policy you buy to supplement your basic workplace policy, creates an additional safety net so your family won't have to rely solely on your basic workplace life insurance. The importance of this type of protection grows as your financial obligations evolve.
We spoke with two life insurance experts to find out when you should consider supplemental life insurance and how to figure out how much coverage is appropriate for your situation.
When should you boost your supplemental life insurance, according to experts?
To better understand when it may (or may not be) appropriate to increase your supplemental life insurance coverage, it first helps to understand the various types of supplemental policies available.
Supplemental life insurance policies come in a few different forms. First, many employers offer supplemental life insurance in addition to their basic plan. You can also purchase a private policy directly through an insurance company.
Both options have some advantages. A group policy, such as one you'd get through your employer, typically doesn't require a medical exam and may come at a cheaper price tag. However, if you lose your job, your insurance goes with it. And you may find that it's more expensive or more difficult to get a different policy later on.
Private plans have the disadvantage of being more expensive and more difficult to qualify for — health histories and medical exams are often required. However, once you lock in your policy, you'll have coverage for your entire term, even if you lose your job.
You can also choose between term and whole life insurance. Term life insurance is the most affordable and provides a set death benefit for a specific number of years. Whole life insurance, meanwhile, covers you for your whole life as long as you continue to make payments and usually has a cash-value component in addition to the death benefit. However, these plans are more expensive.
"Term insurance is usually the best choice for most people: it's affordable and provides substantial coverage during your high-need years," says Foguth. "Permanent insurance has its place, but only if you've already maxed out other financial priorities."
Depending on your situation, supplemental coverage may or may not be the right choice for you. You'll probably want to consider supplemental life insurance if your basic workplace policy has a low death benefit, especially if your family financially depends on you and your income.
Certain life milestones could be a sign it's time to reconsider your life insurance coverage and boost your supplemental coverage.
"We find that younger families in particular need supplemental life insurance," says Matt Hylland, a financial planner and investment advisor with Arnold and Mote Wealth Management. "For one reason, workplace group life insurance is usually based on a multiple of your salary, and younger workers may not yet be at peak salary, where two or three times their current salary is enough insurance."
"Also, younger families, particularly those with young children, have decades of expenses and goals that insurance needs to help cover. As you age, your insurance need typically decreases, but your 30s and 40s are typically the peak years for insurance needs."
When you go through any major life events use that as an opportunity to reevaluate your coverage.
How to calculate your life insurance needs
There are a few different rules of thumb that experts tout for determining your life insurance needs. For example, some recommend multiplying your income by a certain amount, such as 10 times. Others base it on your age and how close you are to retirement. While these methods can be a good starting point, they don't take into account your unique financial situation and needs.
Rather than relying on a basic rule of thumb, consider what purposes your life insurance would serve. Would it provide income for your family? Help pay off your household debt? Send your kids to college? Take all of that into account to decide how much coverage makes sense for you.
For example, you may need to substitute your income at least until your kids head off to college. If you make $75,000 per year and your youngest graduates from high school in ten years, that's $750,000 in coverage. Then, you may choose to add in your family's total debt obligations, including your mortgage, auto loans, credit cards and anything else. Finally, if your goal is to pay for your children's college educations, consider enough coverage to do that.
It's also important to consider what insurance term you need. According to Hylland, it's important to match your life insurance policy with your family's needs. For example, you might choose a policy that's set to end once your kids have moved out of the home or you've paid off your mortgage.
"We also generally say to be conservative and purchase insurance with a slightly longer term than you need," says Hylland. "For example, if your kids will be graduated from college in 15 years, perhaps go with a 20-year term policy. You can always surrender or cancel a term policy if you do not need it, but it will be costly to get insurance later in life if you find that you need additional years of coverage."
It's worth noting that, in some cases, a supplemental policy through your employer still may not be enough. It's important to run the numbers for yourself to make sure you have enough coverage, even if that means purchasing private insurance in addition to your workplace plan.
The bottom line
Almost anyone can benefit from some sort of life insurance, and it's usually non-negotiable for anyone with a family to support. Unfortunately, a basic workplace life insurance plan doesn't usually provide enough coverage.
Make sure to review your life insurance coverage regularly, especially as open enrollment rolls around. It's important to weigh all of your options when you're shopping for policies, including deciding between a term or permanent policy and a workplace or private policy.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Why Casella Waste Systems Stock Flopped on Friday
Key Points The company's bottom-line miss in its second quarter was striking. That was compounded by a guidance reduction for full-year profitability. 10 stocks we like better than Casella Waste Systems › Solid waste and recycling management company Casella Waste Systems (NASDAQ: CWST) was surely eager to start its weekend. On Friday, the company published quarterly results that were a dud with investors, who sent its share price down by more than 5%. That was more deeply in the red than the S&P 500 index's 1.6% dive. One big whiff Much of this was because of a fairly wide bottom-line miss in Casella's second quarter, the results of which were published after market close Thursday. In the quarter, Casella booked revenue of over $465 million. So far, so good, as this was more than 23% higher than in the same quarter of 2024. Further down the profit and loss statement, however, the company revealed that its generally accepted accounting principles (GAAP) net income fell to $5.2 million ($0.08 per share) from the year-ago profit of slightly over $7 million. That drop was discouraging enough, but it was exacerbated by the fact that analysts were expecting far better from the company. On average, they were modeling $0.33 per share for bottom-line profitability, although they underestimated revenue with a collective $454 million projection. Acquisitions played a role in Casella's top-line growth, as the company completed six buyouts across the first half of this year. Management also said higher landfill volumes were a catalyst. Notable guidance revisions Outside of the bottom-line miss, Casella's change in guidance was dismaying for investors. Although it raised its outlook for full-year 2025 revenue -- $1.82 billion to $1.84 billion from just under $1.78 billion to a bit over $1.8 billion -- it cut that for profitability. The company now believes its GAAP net income will land at $8 million to $18 million; the previous guidance called for $10 million to $25 million. Should you buy stock in Casella Waste Systems right now? Before you buy stock in Casella Waste Systems, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Casella Waste Systems wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Casella Waste Systems Stock Flopped on Friday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
Why Novo Nordisk Stock Bumped Higher on Friday
Key Points The Federal government might boost its support of weight-loss drugs soon. According to a media report, it's contemplating a five-year, experimental program that would subsidize their costs for qualifying patients. 10 stocks we like better than Novo Nordisk › Unexpected news of a potential support program from the federal government boosted the share prices of weight-loss drug developers on Friday. The poster boy for that still rather small group, Wegovy/Ozempic maker Novo Nordisk (NYSE: NVO), understandably saw a stock price lift that day. It rose by more than 2%, contrasting well with the 1.6% slide of the S&P 500 index. Federal help for obesity drugs? That news came from The Washington Post, which published an article stating that the Trump administration is planning an experimental program that would cover the costs of such medications. Citing documents from the Centers for Medicare and Medicaid Services (CMS) it had obtained, the newspaper said the plan would be implemented by state Medicaid administrations. It would also be utilized by Medicare Part D insurance plans. These entities would be allowed to cover weight-loss drugs for qualifying patients. At the moment, Medicare generally covers such treatments for patients who suffer from type 2 diabetes. Both Novo Nordisk's Wegovy and rival Eli Lilly's Zepbound are essentially versions of predecessor diabetes drugs. Some private insurance plans cover obesity medications. The Post wrote that the experimental program will last for five years. Massive potential impact Novo Nordisk hasn't yet commented on the article, but we can be sure the company is excited about the prospect. Combined, Medicare and Medicaid are immense programs. Even if only a few states are willing to cover weight-loss treatments through them, the company could experience a surge in sales. For the stock's investors, this is a potentially very impactful development well worth monitoring. Should you buy stock in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Why Novo Nordisk Stock Bumped Higher on Friday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Addus HomeCare (ADUS) Q2 Earnings: What To Expect
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting results this Monday afternoon. Here's what you need to know. Addus HomeCare missed analysts' revenue expectations by 0.6% last quarter, reporting revenues of $337.7 million, up 20.3% year on year. It was a mixed quarter for the company, with a narrow beat of analysts' sales volume estimates. Is Addus HomeCare a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Addus HomeCare's revenue to grow 20.8% year on year to $346.5 million, improving from the 10.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.46 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Addus HomeCare has missed Wall Street's revenue estimates three times over the last two years. Looking at Addus HomeCare's peers in the senior health, home health & hospice segment, some have already reported their Q2 results, giving us a hint as to what we can expect. BrightSpring Health Services delivered year-on-year revenue growth of 15.3%, beating analysts' expectations by 5.2%, and Option Care Health reported revenues up 15.4%, topping estimates by 4.6%. Option Care Health traded down 2.7% following the results. Read our full analysis of BrightSpring Health Services's results here and Option Care Health's results here. The euphoria surrounding Trump's November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the senior health, home health & hospice stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. Addus HomeCare is down 5.3% during the same time and is heading into earnings with an average analyst price target of $136.45 (compared to the current share price of $104.74). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data